Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,717 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
Prados MD, Wara WM, Sneed PK, McDermott M, Chang SM, Rabbitt J, Page M, Malec M, Davis RL, Gutin PH, Lamborn K, Wilson CB, Phillips TL, Larson DA. Prados MD, et al. Among authors: page m. Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):71-7. doi: 10.1016/s0360-3016(00)01458-9. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163499 Clinical Trial.
Temozolomide in the treatment of recurrent malignant glioma.
Chang SM, Theodosopoulos P, Lamborn K, Malec M, Rabbitt J, Page M, Prados MD. Chang SM, et al. Among authors: page m. Cancer. 2004 Feb 1;100(3):605-11. doi: 10.1002/cncr.11949. Cancer. 2004. PMID: 14745879 Free article. Clinical Trial.
Quality of life in low-grade glioma patients receiving temozolomide.
Liu R, Solheim K, Polley MY, Lamborn KR, Page M, Fedoroff A, Rabbitt J, Butowski N, Prados M, Chang SM. Liu R, et al. Among authors: page m. Neuro Oncol. 2009 Feb;11(1):59-68. doi: 10.1215/15228517-2008-063. Epub 2008 Aug 19. Neuro Oncol. 2009. PMID: 18713953 Free PMC article.
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.
Prados MD, Chang SM, Butowski N, DeBoer R, Parvataneni R, Carliner H, Kabuubi P, Ayers-Ringler J, Rabbitt J, Page M, Fedoroff A, Sneed PK, Berger MS, McDermott MW, Parsa AT, Vandenberg S, James CD, Lamborn KR, Stokoe D, Haas-Kogan DA. Prados MD, et al. Among authors: page m. J Clin Oncol. 2009 Feb 1;27(4):579-84. doi: 10.1200/JCO.2008.18.9639. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075262 Free PMC article. Clinical Trial.
1,717 results